Incentivising The Development Of New Antibacterial Treatments.

Written By SECURE The Antibiotic Facility

Following the call to action in December 2021 under the UK’s G7 Presidency, the Global AMR R&D Hub and WHO submitted a joint progress report on actions to incentivise the development of new antibacterial treatments to the G7 Health and Finance ministers.

SECURE The Antibiotic Facility
Previous

Statement from the Minister of Health on Canada’s Support for International Cooperation on Antimicrobial Resistance
Next

Lack of access to medicine is a major driver of drug resistance. How can pharma take action?